Neuroprotective effects of osmotin in Parkinson’s disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways

[1]  Junqiang Yan,et al.  Idebenone improves motor dysfunction, learning and memory by regulating mitophagy in MPTP-treated mice , 2022, Cell death discovery.

[2]  S. Fietz,et al.  Alpha-Synuclein Pathology Coincides With Increased Number of Early Stage Neural Progenitors in the Adult Hippocampus , 2021, Frontiers in Cell and Developmental Biology.

[3]  Hyoung-Gon Lee,et al.  Adiponectin-mimetic novel nonapeptide rescues aberrant neuronal metabolic-associated memory deficits in Alzheimer’s disease , 2021, Molecular neurodegeneration.

[4]  A. Nebreda,et al.  Diversity and versatility of p38 kinase signalling in health and disease , 2021, Nature Reviews Molecular Cell Biology.

[5]  M. Kim,et al.  Quinpirole-Mediated Regulation of Dopamine D2 Receptors Inhibits Glial Cell-Induced Neuroinflammation in Cortex and Striatum after Brain Injury , 2021, Biomedicines.

[6]  M. Asanuma,et al.  Neuron-Astrocyte Interactions in Parkinson’s Disease , 2020, Cells.

[7]  Jessica K. Gagnon,et al.  ERK signalling: a master regulator of cell behaviour, life and fate , 2020, Nature Reviews Molecular Cell Biology.

[8]  Jessica K. Gagnon,et al.  ERK signalling: a master regulator of cell behaviour, life and fate , 2020, Nature Reviews Molecular Cell Biology.

[9]  Bin Zhang,et al.  Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration , 2019, Nature Communications.

[10]  M. Brini,et al.  A split-GFP tool reveals differences in the sub-mitochondrial distribution of wt and mutant alpha-synuclein , 2019, Cell Death & Disease.

[11]  M. Jo,et al.  Adiponectin homolog osmotin, a potential anti-obesity compound, suppresses abdominal fat accumulation in C57BL/6 mice on high-fat diet and in 3T3-L1 adipocytes , 2019, International Journal of Obesity.

[12]  M. Kim,et al.  Hesperetin Confers Neuroprotection by Regulating Nrf2/TLR4/NF-κB Signaling in an Aβ Mouse Model , 2019, Molecular Neurobiology.

[13]  Z. Qin,et al.  NADPH ameliorates MPTP-induced dopaminergic neurodegeneration through inhibiting p38MAPK activation , 2019, Acta Pharmacologica Sinica.

[14]  A. Filipek,et al.  Role of Mitogen Activated Protein Kinase Signaling in Parkinson’s Disease , 2018, International journal of molecular sciences.

[15]  D. Lodge,et al.  Adiponectin modulates ventral tegmental area dopamine neuron activity and anxiety-related behavior through AdipoR1 , 2018, Molecular Psychiatry.

[16]  Xiaoshuang Zhou,et al.  Trx‐1 ameliorates learning and memory deficits in MPTP‐induced Parkinson's disease model in mice , 2018, Free radical biology & medicine.

[17]  M. Kim,et al.  The Adiponectin Homolog Osmotin Enhances Neurite Outgrowth and Synaptic Complexity via AdipoR1/NgR1 Signaling in Alzheimer’s Disease , 2018, Molecular Neurobiology.

[18]  I. Zerr,et al.  α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B , 2017, Nature Neuroscience.

[19]  E. Masliah,et al.  Importance of adiponectin activity in the pathogenesis of Alzheimer's disease , 2017, Annals of clinical and translational neurology.

[20]  D. Bennett,et al.  Selective lowering of synapsins induced by oligomeric α-synuclein exacerbates memory deficits , 2017, Proceedings of the National Academy of Sciences.

[21]  P. Bregestovski,et al.  Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson’s disease , 2017, Proceedings of the National Academy of Sciences.

[22]  A. Giese,et al.  Seeding and transgenic overexpression of alpha‐synuclein triggers dendritic spine pathology in the neocortex , 2017, EMBO molecular medicine.

[23]  L. Parnetti,et al.  Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease , 2017, Molecular Neurodegeneration.

[24]  H. Y. Lee,et al.  Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits , 2016, Molecular Psychiatry.

[25]  M. Xilouri,et al.  Autophagy and Alpha‐Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies , 2016, Movement disorders : official journal of the Movement Disorder Society.

[26]  M. Verrier,et al.  The effects of aquatic therapy on mobility of individuals with neurological diseases: a systematic review , 2015, Clinical rehabilitation.

[27]  Guoqi Zhu,et al.  MPTP‐induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF‐TrkB pathway , 2015, British journal of pharmacology.

[28]  A. Xu,et al.  Adiponectin Stimulates Autophagy and Reduces Oxidative Stress to Enhance Insulin Sensitivity During High-Fat Diet Feeding in Mice , 2014, Diabetes.

[29]  S. Inoue,et al.  Disease modifying effect of adiponectin in model of α-synucleinopathies , 2014, Annals of clinical and translational neurology.

[30]  H. Y. Lee,et al.  Novel osmotin attenuates glutamate-induced synaptic dysfunction and neurodegeneration via the JNK/PI3K/Akt pathway in postnatal rat brain , 2014, Cell Death and Disease.

[31]  K. Gysling,et al.  Nur transcription factors in stress and addiction , 2013, Front. Mol. Neurosci..

[32]  D. Klionsky,et al.  The role of autophagy in Parkinson's disease. , 2012, Cold Spring Harbor perspectives in medicine.

[33]  Lei Zhang,et al.  The role of autophagy in Parkinson's disease , 2012, Behavioral and Brain Functions.

[34]  Tapan P. Patel,et al.  Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death , 2011, Neuron.

[35]  J. Trojanowski,et al.  α-Syn Suppression Reverses Synaptic and Memory Defects in a Mouse Model of Dementia with Lewy Bodies , 2011, The Journal of Neuroscience.

[36]  E. Choi,et al.  Pathological roles of MAPK signaling pathways in human diseases. , 2010, Biochimica et biophysica acta.

[37]  Shin-ichi Muramatsu,et al.  Nurr1 Is Required for Maintenance of Maturing and Adult Midbrain Dopamine Neurons , 2009, The Journal of Neuroscience.

[38]  V. Baekelandt,et al.  Alpha-synuclein A30P point-mutation generates age-dependent nigrostriatal deficiency in mice. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[39]  M. Lew.  Overview of Parkinson's Disease , 2007, Pharmacotherapy.

[40]  S. Przedborski,et al.  Protocol for the MPTP mouse model of Parkinson's disease , 2007, Nature Protocols.

[41]  E. Kang,et al.  Adiponectin protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. , 2006, Biochemical and biophysical research communications.

[42]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.

[43]  D. Yun,et al.  Osmotin is a homolog of mammalian adiponectin and controls apoptosis in yeast through a homolog of mammalian adiponectin receptor. , 2005, Molecular cell.

[44]  M. Hetman,et al.  Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. , 2004, European journal of biochemistry.

[45]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[46]  S. Fahn.  Description of Parkinson's Disease as a Clinical Syndrome , 2003, Annals of the New York Academy of Sciences.

[47]  Nancy A. Jenkins,et al.  Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[48]  E. Masliah,et al.  α-Synuclein is phosphorylated in synucleinopathy lesions , 2002, Nature Cell Biology.

[49]  M. Sheng,et al.  Regulation of Dendritic Spine Morphology by SPAR, a PSD-95-Associated RapGAP , 2001, Neuron.

[50]  M. Beal,et al.  Experimental models of Parkinson's disease , 2001, Nature Reviews Neuroscience.

[51]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[52]  D. Rubinsztein,et al.  Alpha-synuclein overexpression promotes aggregation of mutant huntingtin. , 2000, The Biochemical journal.

[53]  M. Kim,et al.  Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models. , 2019, Metabolism: clinical and experimental.

[54]  M. Kim,et al.  Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway , 2018, Molecular Neurobiology.

[55]  Xiaohong Sun,et al.  DJ-1 upregulates tyrosine hydroxylase gene expression by activating its transcriptional factor Nurr1 via the ERK1/2 pathway. , 2012, The international journal of biochemistry & cell biology.

[56]  C. Shaw,et al.  Neurodegenerative Diseases: Neurotoxins as Sufficient Etiologic Agents? , 2007, NeuroMolecular Medicine.

[57]  Michael L. Kramer,et al.  Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[58]  J. Schulz.  Mechanisms of neurodegeneration in idiopathic Parkinson's disease. , 2007, Parkinsonism & related disorders.

[59]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[60]  D. Price,et al.  Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[61]  E. Masliah,et al.  alpha-Synuclein is phosphorylated in synucleinopathy lesions. , 2002, Nature cell biology.